期刊文献+

应用亚甲蓝行乳腺癌前哨淋巴结活检276例分析 被引量:1

Methylene blue guided sentinel lymph node biopsy in 276 breast cancer patients
原文传递
导出
摘要 目的探讨以亚甲蓝作为示踪剂行乳腺癌前哨淋巴结(SLN)活检的临床应用及影响因素。方法分析了276例临床T1-T2N0M0乳腺癌患者前哨淋巴结活检(SLNB)结果,对SLN检出率及假阴性率影响因素进行了初步分析。结果276例患者中,成功检出SLN者246例(检出率为89.1%)。共检出SLN423枚,每例1~4枚。前哨淋巴结对腋窝淋巴结转移情况预测的敏感性为77.3%(68/88),假阴性率为8.1%(20/246),假阳性率为0,准确率为91.9%(226/246)。临床T2N0M0SLNB成功率高于临床T1N0M0乳腺癌患者(P=0.046);年龄〈50岁者SLNB检出成功率高于年龄≥50岁病例(P=0.000),SLNB假阴性率年龄〈50岁者显著低于高龄患者(P=0.037);外上象限和外下象限肿瘤SLNB检出成功率明显高于其他象限(P=0.000)。内上象限肿瘤SLNB假阴性率高于外上及外下象限(P=0.018)。临床TMN分期、ER、PR表达情况及病理类型对SLNB成功率及假阴性率无影响。结论以亚甲蓝作为示踪剂行乳腺癌SLNB,患者年龄、临床TNM分期、肿瘤部位对SLN检出率有一定影响,患者年龄、肿瘤部位可影响SLNB假阴性率。 Objective To evaluate the feasibility of methylene blue as a method in lymphatic mapping and the effect factors of SLNB identification rate. Methods The results of SLNB in 276 patients with clinical stage T1 -T2 N0M0 breast cancer were analyzed to evaluate the effect factors of identification rate and false-negative rate of SLNB. Results The identification of SLN was carried out using methylene blue . When the mapping time of SLN and lymphatic were controlled in 20 - 30 minutes, the SLN could be visualized easily. SLN was successfully identified in 246 of 276 patients (89.1% ) ,423 SLNs were retrieved( 1 - 4). The SLN accurately predicted the status of the axilla in 226 of 246 patients (77.3 % ) yielding a FNR (false negative rate ) of 8.1% (20/246), false positive rate of 0, and an accuracy of 91.9% (226/241). For the identified rate of SLN, the clinical stage of T2N0M0 disease was higher than the clinical stage of T1N0M0 disease (P = 0. 046,P 〈 0.05), Upper outer quadrant and lower outer quadrant were higher than other evidently ( P 〈 0. 0010). SLNs were easily retrieved in those cases aged above 50 years than below 50 years (P 〈0.001 ). In the view of false-negative rate of SLNB, the FNR rate in patients of 50 years old was less than older ones (P = 0.037, P 〈 0.05 ). No significant correlation was found between the stage of TMN, the expression of ER and PR, histologic status and FNR. Conclusion When SLNB was performed using methylene blue, we found age, clinical stage of TMN, the location of tumor had relationship with the identified rate of SLN. Aging and location of tumor may adversely affect FNR of SLNB.
出处 《国际外科学杂志》 2009年第7期460-463,共4页 International Journal of Surgery
关键词 乳腺肿瘤 亚甲蓝 前哨淋巴结 淋巴转移 活组织检查 breast cancer methylene blue sentinel lymph node excisional biopsy
  • 相关文献

参考文献12

  • 1Uren RF,Howman-Giles R,Renwick SB,et al.Lymphatic mapping of the breast:locating the sentinel lymph nodes[J].World Surg,2001,25(6):789-793.
  • 2Crosein JA,Johnson AC,Stewart PB,et al.Ganunaprobe-guided resection of the sentinel lymph node in breast cancer[J].Am Surg,1998,64(7):666-669.
  • 3Cabanas RM.An approach for the treatment of penile carcinoma[J].Cancer,1977,39(2):456-466.
  • 4Canavese G.Pattern of lymph node in breast cancer pationts[J].J Stag Oncol,2000,74(1):69-74.
  • 5Ginliano AE,Haigh PI,Brennan MB,et al.Prospective observational study of sentinel lymphadenectomy without further axillary dissection in patients with sentinel node negative breast cancer[J].J Clin Oncol,2000,18(13):2553-2258.
  • 6Krag D,Weaver D,Ashikaga T,et al.The sentinel node in breast cancer:a multicentor validation study[J].N Engl J Med,1998,339(6):941-945.
  • 7McMasters KM,Tuttle TM,Carlson DJ,et al.Sentinel lymph node biopsy for breast cancer:a suitable alternative to routine sxillary dissection in multi-institutional practice when optimal technique is used[J].J Clin Oncol,2000,18(13):2560-2564.
  • 8Fukui I,Yokokawa M,Mitani G,et al.In vivo stainingest with methylene blue for bladder caner[J].J Urol,1983,130 (2):2522-2526.
  • 9沈坤炜,Nirmal Lamichhane,韩企夏,吴炅,陆劲松,张家新,柳光宇,邵志敏,沈镇宙.乳腺癌前哨淋巴结活检[J].中华外科杂志,2002,40(5):347-350. 被引量:31
  • 10陈国际,张保宁,邵永孚,刘琳,杨红鹰.乳腺癌前哨淋巴结活检的临床研究[J].实用癌症杂志,2004,19(1):53-55. 被引量:4

二级参考文献12

  • 1Krag D, Weaver D, Ashikaga T, et al. The sentinel node in breast cancer:a multicenter validation study[J]. N Engl J Med, 1998,339(14) : 941.
  • 2McMasters KM, Tuttle TM, Carlson DJ, et al. Sentinel lymph node biopsy for breast cancer: a suitable alternative to routine axillary dissection in multi-institutional practice when optimal technique is used[J]. J Clin Oncol, 2000,18 (13) : 2560.
  • 3Feldman SM, Krag DN, McNally RK ,et al. Limitation in gamma probe localization of the sentinel node in breast cancer patients with large excisional biopsy [J]. J Am Coll Surg, 1999,188(3) :248.
  • 4Noguchi M, Motomura K, Imoto S,et al. A multicentric validation study of sentinel lymph node biopsy by the Japanese Breast Cancer Society [J]. Breast Cancer Res Treat, 2000,63(1) : 31.
  • 5Mcmasters KM, Gialiano AE, Ross MI, et al. Sentinellymph-node biopsy for breast cancer-not yet the standard of care [J ]. N Eng J Med, 1998,339 (14) : 990.
  • 6Rosen PP, Lesser ML, Kinne DM, et al. Discontinuous or "skip" metastasis in breast carcinoma: analysis of 1228 axillary dissections[J]. Ann Surg, 1983,197(3) : 276.
  • 7Dowlatshahi K, Fan M, Snider HC, et al. Lymph node micrometastases from breast carcinoma: reviewing the dilemma [J ]. Cancer, 1997,80 (7) :1188.
  • 8Cabanas RM. An approach for the treatment of penile carcinoma[J ]. Cancer, 1977,39(2) :456.
  • 9Turner RR, Ollila DW, Krasne DL, et al. Histopathological validation of the sentinel lymph node hypothesis for breast cancer[J]. Ann Surg, 1997,226(3) -271.
  • 10Weaver DL, Krag DN, Ashikaga T, et al. Pathological analysis of sentinel and nonsentinel lymph nodes in breast carcinoma- a multicenter study [J]. Cancer, 2000,88(5) :1099.

共引文献33

同被引文献10

  • 1Leong SP, Shen ZZ, Liu TJ, et al. Is breast cancer the same dis- ease in Asian and Western countries[ J] ? World J Surg, 2010, 34 (10) : 2308-2324.
  • 2Yoo GJ, Ievine EG, Aviv C, et at. Older women,breast cancer, and social support [ J]. Support Care Cancer, 2010, 18 (12) : 1021-1530.
  • 3Lyman GH, Guiliano AE, Somerfield MR, et al. American Society of Clinical Oncology guideline recommendations for sentinel lymph node biopsy in early-stage breast cancer[J] J Clin Oneol, 2005, 23(30) : 7703-7720.
  • 4Peley G, Sinkovies I, Toth J, et at. Subaredar injection of radioac- tive colloid for sentinel lymph node identification in breast cancer patients[J]. AM Surg, 2004, 70(7): 625-629.
  • 5Krag DN, Anderson SJ, Julian TB, et al. Sentinel-lymph- node re- section compared with conventional axillary-lymph-node dissection in clinically node-negative patients with breast cancer: overall sur- vival findings from the NSABP B-32 randomised phase 3 trial[ J]. Lancet Oncol, 2010, 11 (10) : 927-933.
  • 6Hirano A, Kamimura M, Ogura K, et al. A Comparison of Indocy- anine Green Fluorescence Imaging Plus Blue Dye and Blue Dye A- lone for Sentinel Node Navigation Surgery in Breast Cancer Patients [J]. AnnsurgOneol, 2012, 19(13):4112-4116.
  • 7Chao C, Wong SL, Woo C, et al. Reliable lymphatic drainage to axillary sentinel lymph nodes regardless of tmnor location within the breast[J]. AmJStag, 2001,182(4): 307-311.
  • 8郑刚,杨靖,左文述,于志勇,刘岩松,郑美珠,王圣芳.中国乳腺癌前哨淋巴结活检验证阶段研究结果的系统评价[J].中华医学杂志,2011,91(6):361-365. 被引量:36
  • 9朱敬军,杨金喆,张钢龄,杨七玉,祁燕云,任殿泉,赵志强,白雪峰,曹虹然,张培礼.前哨淋巴结活检术在早期乳腺癌手术中的应用[J].中国医药,2013,8(4):523-524. 被引量:10
  • 10苏逢锡,巴明臣,周晓东,吴仙容,李燕,陈积圣,李君.活体染料注射法识别乳腺癌患者前哨淋巴结失败及假阴性原因分析[J].中华肿瘤杂志,2002,24(3):297-299. 被引量:17

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部